AHIP April 8, 2020
Experts examine various pandemic severity scenarios to model testing and treatment costs
WASHINGTON, D.C. – No one should hesitate to seek testing or treatment for COVID-19 due to concerns about costs. Health insurance providers are taking decisive action to protect patients and support hospitals and doctors during this unprecedented national health emergency.
To get a more complete picture of what COVID-19 costs could be, America’s Health Insurance Plans (AHIP) retained Wakely Consulting Group to explore the potential cost implications of COVID-19 testing and treatment to U.S. health insurance providers for 2020 and 2021. Wakely estimated that the costs to the health care system from COVID-19 could range from $56 billion to $556 billion over the next two years.
Protecting...
Today's Sponsors
Today's Sponsor